Arachidonic acid metabolism by dioxin-induced cytochrome P-450: a new hypothesis on the role of P-450 in dioxin toxicity

Biochemical and Biophysical Research Communications
A B RifkindS S Gross

Abstract

Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) is a highly potent inducer of cytochrome P-450. The role of the induced P-450 in TCDD toxicity has been obscure as P-450 neither detoxifies TCDD nor activates it to genotoxic or cytotoxic metabolites. We show, using a chick embryo model, that TCDD causes major increases in the NADPH dependent metabolism of arachidonic acid (AA), a predominant cell membrane fatty acid, that it does so with extremely high potency (ED50, 6.3 pmol per egg) and that this metabolism is catalyzed by TCDD-induced cytochrome P-450 species. Thus, TCDD treatment increased by six to ten fold the P-450 mediated hepatic microsomal metabolism of AA to epoxides and monohydroxyeicosatetraenoic acids, products whose diverse biological activities suggest links to TCDD's toxic effects. In contrast only x and x-1 hydroxy AA, inactive products, were significantly formed by the controls. These findings open a new perspective on how P-450 induction could be related to the diverse toxic effects of TCDD. They lead to the novel hypothesis that TCDD-induced cytochrome P-450 metabolizes an endogenous fatty acid to reactive products that in turn mediate or modulate varied manifestations of TCDD toxicity.

References

Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B L Scott, N G Bazan
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·L CangaA B Rifkind
Jan 1, 1986·Annual Review of Biochemistry·P NeedlemanJ B Lefkowith
Jan 1, 1987·Journal of Toxicology and Environmental Health·L W WeberK K Rozman
Jun 19, 1987·European Journal of Pharmacology·M A CarrollJ C McGiff
Apr 14, 1986·Biochemical and Biophysical Research Communications·P M Woollard
Sep 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J CapdevilaR W Estabrook
Jun 1, 1983·Archives of Biochemistry and Biophysics·N ChacosR W Estabrook

❮ Previous
Next ❯

Citations

Jul 1, 1994·Trends in Pharmacological Sciences·A B OkeyP A Harper
Feb 1, 1993·Molecular and Cellular Endocrinology·T AnderssonB Breton
Sep 6, 2002·Chemico-biological Interactions·Timothy P DaltonHoward G Shertzer
Feb 11, 1999·Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology·R P Gupta, M B Abou-Donia
Aug 22, 2003·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·J F SavouretR F Casper
Mar 20, 2001·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·K R Olson
Aug 4, 1998·Environmental Toxicology and Pharmacology·A YawetzJ J Stegeman
Jun 26, 2001·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·B StantonB Lasley
Feb 19, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Stephanie P Jones, Sean W Kennedy
Mar 22, 2014·Chemical Research in Toxicology·Sergio ManzettiDavid van der Spoel
Oct 12, 2013·Cell Stress & Chaperones·Kalai Selvi PalaniswamySaranya Ramalingam Singaravelu
Aug 1, 2006·Drug Metabolism Reviews·Hesham M Korashy, Ayman O S El-Kadi
Apr 6, 2005·Toxicology and Applied Pharmacology·Silvia C Billi de CatabbiAdriana C Cochón
Jul 24, 2008·Dose-response : a Publication of International Hormesis Society·John F ReichardAlvaro Puga
Jul 1, 1993·Human & Experimental Toxicology·R GuitartR Fanelli
Jan 1, 1996·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A E VickersJ Guertler
Oct 24, 2001·Journal of Biochemical and Molecular Toxicology·S D SeidelM S Denison
Aug 24, 2019·Environmental Health : a Global Access Science Source·Jørn A HolmeJohan Øvrevik
Nov 16, 2007·Development·Petr ValasekKetan Patel
Jun 2, 1998·Archives of Biochemistry and Biophysics·J J SchlezingerJ J Stegeman
Mar 20, 1992·Journal of Chromatography·V Lang
Dec 22, 1999·Chemico-biological Interactions·H G ShertzerT P Dalton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.